Prospects for the Resistance to HIV Protease Inhibitors: Current Drug Design Approaches and Perspectives

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|24|3077-3090

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.24, 2005-01, pp. : 3077-3090

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Approaches to the Design of Effective HIV-1 Protease Inhibitors

By  

Current Medicinal Chemistry, Vol. 7, Iss. 4, 2000-04 ,pp. : 455-477

Bentham Science Publishers

Access to resources Recommend Favorite

The Cellular Pharmacokinetics of HIV Protease Inhibitors: Current Knowledge and Future Perspectives

By  

Current Drug Metabolism, Vol. 13, Iss. 8, 2012-10 ,pp. : 1174-1183

Bentham Science Publishers

Access to resources Recommend Favorite

Resistance Mutations Against HCV Protease Inhibitors and Antiviral Drug Design

By  

Current Pharmaceutical Design, Vol. 20, Iss. 5, 2014-02 ,pp. : 694-703

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Interactions of HIV Protease Inhibitors

By Malaty L.I.  

Drug Safety, Vol. 20, Iss. 2, 1999-02 ,pp. : 147-169

Adis International

Access to resources Recommend Favorite

HIV Protease Inhibitors: Peptidomimetic Drugs and Future Perspectives

By  

Current Medicinal Chemistry, Vol. 9, Iss. 21, 2002-11 ,pp. : 1905-1922

Bentham Science Publishers

Access to resources Recommend Favorite